Increased Spironolactone in Advanced Heart Failure: Effect of Doses Greater than 25 mg/Day on Plasma Potassium Concentration

Publisher： Karger

E-ISSN： 1664-5502|3|1|1-6

ISSN： 1664-3828

Source： Cardiorenal Medicine, Vol.3, Iss.1, 2013-01, pp. : 1-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spironolactone Treatment and Effect on Survival in Chronic Heart Failure Patients with Reduced Renal Function: A Propensity-Matched Study

By  

Cardiorenal Medicine, Vol. 7, Iss. 2, 2017-01 ,pp. : 128-136

Karger

Access to resources Recommend Favorite

Lack of Diuretic Efficiency (but Not Low Diuresis) Early in An Acutely Decompensated Heart Failure Episode Is Associated with Increased 180-Day Mortality

By  

Cardiorenal Medicine, Vol. 7, Iss. 2, 2017-01 ,pp. : 137-149

Karger

Access to resources Recommend Favorite

Effect of Usual Doses of Folate Supplementation on Elevated Plasma Homocyst(e)ine in Hemodialysis Patients: No Difference between 1 and 5 mg Daily

By  

American Journal of Nephrology, Vol. 19, Iss. 3, 1999-06 ,pp. : 405-410

Karger

Access to resources Recommend Favorite

Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes

By  

American Journal of Nephrology, Vol. 46, Iss. 3, 2017-09 ,pp. : 213-221

Karger

Access to resources Recommend Favorite

Effect of Spironolactone on Impaired Fibrinolysis of Hypertensive Patients

By  

Kidney and Blood Pressure Research, Vol. 25, Iss. 4, 2002-11 ,pp. : 260-264

Karger

Access to resources Recommend Favorite